IPO registrations (S-1, F-1) · Registrants
Alpha Cognition Inc.
- SEC CIK
- 1655923 · filings on EDGAR ↗
- Former names
- Neurodyn Cognition Inc. (2015–2019)
- Registration
- Form S-1, first filed 2024-04-30, last 2025-01-10; 4 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2024-11-13; declared effective 2024-06-07
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- A1
- Business address
- 1452 HUGHES RD., STE. 200, Grapevine, TX 76051
- Ticker
- ACOG (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Alpha Cognition Inc. on the corporate pages
Offering terms
- Final price
- $5.75 per share (424B4 filed 2024-11-13, an initial public offering)
- Shares sold
- 8,695,653
- Gross proceeds
- $50,000,004 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ACOG
- Lead underwriters
- Titan Partners; American Capital Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Alpha Cognition Inc. EXACT (CIK (EXACT))
- SEC filer: Alpha Cognition Inc. EXACT (CIK (EXACT))
Filings 22
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-04-30 | S-1 | S-1 (registration) | Alpha Cognition Inc. | 0001213900-24-037413 ↗ |
| 2024-05-10 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-041780 ↗ |
| 2024-05-22 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-045921 ↗ |
| 2024-06-04 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-049203 ↗ |
| 2024-06-07 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-24-001784 ↗ |
| 2024-06-14 | S-1 | S-1 (registration) | Alpha Cognition Inc. | 0001213900-24-052607 ↗ |
| 2024-07-30 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001013762-24-002238 ↗ |
| 2024-10-16 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-088111 ↗ |
| 2024-10-16 | S-1 | S-1 (registration) | Alpha Cognition Inc. | 0001213900-24-088116 ↗ |
| 2024-10-23 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-24-003253 ↗ |
| 2024-10-25 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-090875 ↗ |
| 2024-11-06 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-24-094839 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-24-003416 ↗ |
| 2024-11-12 | S-1MEF | S-1MEF (added securities) | Alpha Cognition Inc. | 0001213900-24-096308 ↗ |
| 2024-11-13 | 424B4 | 424B4 (final prospectus) | Alpha Cognition Inc. | 0001213900-24-097035 ↗ |
| 2024-12-31 | S-1 | S-1 (registration) | Alpha Cognition Inc. | 0001213900-24-114064 ↗ |
| 2025-01-10 | S-1/A | S-1/A (amendment) | Alpha Cognition Inc. | 0001213900-25-002277 ↗ |
| 2025-01-13 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-25-000085 ↗ |
| 2025-01-13 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-25-000093 ↗ |
| 2025-07-08 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-25-002195 ↗ |
| 2025-07-25 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-25-002363 ↗ |
| 2025-08-29 | EFFECT | EFFECT (declared effective) | Alpha Cognition Inc. | 9999999995-25-002794 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-06 | S-1/A | registration statement | $5.50 | 4,000,000 | $22,000,000 | Nasdaq ACOG | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ | |
| 2024-11-13 | 424B4 | final prospectus | $5.75 | 8,695,653 | $50,000,004 | Nasdaq ACOG | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BAKSHI RAJEEV KUMAR | Director | 3 | 2024–2026 | ||
| CAWKELL KENNETH ANTHONY | Director | 3 | 2024–2026 | ||
| D'Angelo Lauren | Officer | Chief Operating Officer | 4 | 2024–2026 | |
| HAVENS JOHN PRENTISS | Director | 3 | 2024–2025 | ||
| McFadden Michael E. | Director,Officer | Chief Executive Officer | 4 | 2024–2026 | |
| MERTZ LEONARD POWELL | Director | 5 | 2024–2026 | ||
| MERTZ PHILLIP JOSEPH | Director | 4 | 2024–2026 | ||
| DU HENRY HUY | Officer | VP Finance and Accounting | 2 | 2024–2026 | |
| Wills Robert James | Director | 5 | 2025–2026 | ||
| Opaleye Management Inc. | TenPercentOwner | 24 | 2026 | ||
| Sensenig Bethany | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-11-18 | Alpha Cognition Inc. | Biotechnology | $346,944 | $0 | 1 | 1 |
| 2024-10-09 | Alpha Cognition Inc. | Biotechnology | $11,143,857 | $4,545,000 | 22 | 1 |
| 2024-01-31 | Alpha Cognition Inc. | Biotechnology | $6,840,921 | $2,839,628 | 60 | 1 |
| 2024-01-05 | Alpha Cognition Inc. | Biotechnology | $4,245,053 | $1,762,097 | 30 | 1 |
| 2023-11-20 | Alpha Cognition Inc. | Biotechnology | $1,721,588 | $1,009,999 | 13 | 1 |
| 2023-10-19 | Alpha Cognition Inc. | Biotechnology | $586,361 | $343,999 | 9 | 1 |
| 2023-09-12 | Alpha Cognition Inc. | Biotechnology | $2,149,152 | $1,260,837 | 28 | 1 |
| 2023-03-28 | Alpha Cognition Inc. | Biotechnology | $3,254,716 | $1,286,748 | 14 | 1 |
| 2023-02-28 | Alpha Cognition Inc. | Biotechnology | $4,673,916 | $1,847,827 | 8 | 1 |
| 2021-10-18 | Alpha Cognition Inc. | Biotechnology | $920,796 | $424,983 | 3 | 1 |
| 2020-12-28 | Alpha Cognition Inc. | Biotechnology | $1,457,000 | $1,457,000 | 18 | 1 |
| 2020-05-01 | Alpha Cognition Inc. | Biotechnology | $1,915,000 | $1,915,000 | 9 | 1 |
| 2019-10-09 | Neurodyn Cognition Inc. | Biotechnology | $5,951,093 | $5,951,093 | 14 | 1 |
| 2018-07-20 | Neurodyn Cognition Inc. | Biotechnology | $4,000,000 | $2,000,000 | 6 | 1 |
| 2017-12-19 | Neurodyn Cognition Inc. | Biotechnology | $200,000 | $200,000 | 1 | 1 |
| 2016-04-26 | Neurodyn Cognition Inc. | Biotechnology | $385,000 | $385,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Alpha Cognition Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Alpha Cognition Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), TX first:
- ILEX ONCOLOGY INC TX
- HEMOBIOTECH, INC. TX
- Peloton Therapeutics, Inc. TX
- Instil Bio, Inc. TX
- Kiromic Biopharma, Inc. TX
- Taysha Gene Therapies, Inc. TX
- CG Oncology, Inc. TX
- Voyager Acquisition Corp./Cayman Islands TX
- STEM CELL INNOVATIONS, INC. TX
- REPROS THERAPEUTICS INC. TX
In other datasets, the same topic (Health) in TX:
- Nonprofit: AARON ALEXANDERS CLUB NICU (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health